Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
作者信息
Bae Sun Hwan, Kim Jae Seon, Kim Dong Hoon
机构信息
Department of Pediatrics, School of Medicine, Konkuk University, Gwangjin-gu, Seoul, Korea.
出版信息
J Korean Med Sci. 2006 Aug;21(4):758-60. doi: 10.3346/jkms.2006.21.4.758.
Abstract
Prednisone or prednisolone are the mainstay drug treatments for autoimmune hepatitis in children. However, long-term use of corticosteroid is associated with the risk of steroid-induced toxicities, and this situation requires newer immuno-suppressive agents for the treatment of autoimmune hepatitis, especially in growing children. An 11-yr-old Korean girl with type-1 autoimmune hepatitis discontinued prednisolone due to toxicities, i.e., hirsutism, buffalo hump, and skin striae, and remained clinical and biochemical remission under replacement of deflazacort and ursodeoxycholic acid combination therapy. A follow-up liver biopsy after 19 months of deflazacort and ursodeoxycholic acid treatment showed histologic remission.
摘要
相似文献
1
Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
J Korean Med Sci. 2006 Aug;21(4):758-60. doi: 10.3346/jkms.2006.21.4.758.
2
Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Gastroenterol Clin Biol. 2005 Nov;29(11):1173-6. doi: 10.1016/s0399-8320(05)82185-2.
3
Acute seronegative autoimmune hepatitis.
Hepatogastroenterology. 2010 Mar-Apr;57(98):334-5.
4
Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Hepatogastroenterology. 2002 Sep-Oct;49(47):1195-200.
5
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.
J Gastroenterol Hepatol. 2000 Jan;15(1):95-8. doi: 10.1046/j.1440-1746.2000.02054.x.
6
Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):490. doi: 10.1097/MPG.0b013e3180dca0b3.
7
Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
Rev Esp Enferm Dig. 1999 Sep;91(9):630-8.
8
[Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Eksp Klin Gastroenterol. 2010(8):113-7.
9
Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
J Hepatol. 2006 Feb;44(2):400-6. doi: 10.1016/j.jhep.2005.10.017. Epub 2005 Nov 15.
10
[Recent progress in the diagnosis and therapy of autoimmune hepatitis].
Nihon Naika Gakkai Zasshi. 1999 Sep 10;88(9):1763-7.
引用本文的文献
1
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.
World J Gastroenterol. 2017 Sep 7;23(33):6030-6048. doi: 10.3748/wjg.v23.i33.6030.
2
Deflazacort in comparison to other steroids for nephrotic syndrome.
Indian J Nephrol. 2012 Jul;22(4):239-45. doi: 10.4103/0971-4065.101238.
本文引用的文献
1
Deflazacort for the treatment of Duchenne Dystrophy: a systematic review.
BMC Neurol. 2003 Sep 8;3:7. doi: 10.1186/1471-2377-3-7.
2
Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
Autoimmunity. 2002 Dec;35(8):515-9. doi: 10.1080/0891693021000056721.
3
Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
Pediatr Nephrol. 2000 Jul;14(7):682-8. doi: 10.1007/s004670000337.
4
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.
J Hepatol. 1999 Nov;31(5):929-38. doi: 10.1016/s0168-8278(99)80297-9.
5
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
Hepatology. 1999 Dec;30(6):1381-6. doi: 10.1002/hep.510300603.
6
Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
Rev Esp Enferm Dig. 1999 Sep;91(9):630-8.
7
Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis.
J Gastroenterol Hepatol. 1998 May;13(5):490-5. doi: 10.1111/j.1440-1746.1998.tb00674.x.
8
Autoimmune hepatitis in childhood: a 20-year experience.
Hepatology. 1997 Mar;25(3):541-7. doi: 10.1002/hep.510250308.
9
Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
Drugs. 1995 Aug;50(2):317-33. doi: 10.2165/00003495-199550020-00008.
10
Malignancies following long-term azathioprine treatment in chronic liver disease. A report from the Copenhagen Study Group for Liver Diseases.
Liver. 1987 Apr;7(2):81-3. doi: 10.1111/j.1600-0676.1987.tb00321.x.
Zotero 插件